"gp100209–2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T Cells" by Edwin B. Walker

Selected Works of Walter J. Urba, MD, PhD

Article

gp100209–2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T Cells

Clinical Cancer Research (2004)

Edwin B. Walker, Providence Portland Medical Center
Daniel Haley, Providence Regional Medical Center Everett
William Miller, Northwestern University
Kevin Floyd, Providence Portland Medical Center
Ketura P. Wisner, Providence Portland Medical Center
Nelson Sanjuan
Holden Maecker, Becton Dickinson
Pedro Romero, Ludwig Institute for Cancer Research
Hong-Ming Hu, Providence Portland Medical Center
W. Gregory Alvord, National Institutes of Health
John W. Smith, Loyola University Chicago
Bernard A. Fox, Providence Portland Medical Center
Walter J. Urba, Providence Portland Medical Center

Link

Disciplines

Publication Date

January 15, 2004

DOI

10.1158/1078-0432.CCR-0095-03

Citation Information

Edwin B. Walker, Daniel Haley, William Miller, Kevin Floyd, et al.. "gp100209–2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T Cells" Clinical Cancer Research Vol. 10 Iss. 2 (2004) p. 668 - 680
Available at: http://works.bepress.com/walter-urba/211/